$4.86
-0.08-1.67%
Last update: 3:04 PM
15 minutes delayed
Fennec Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fennec Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.20 | $-0.03 | -566.7 % |
Mar 2024 | 2024-05-14 | $0.41 | $0.26 | 57.7 % |
Dec 2023 | 2024-03-21 | $-0.10 | $-0.02 | -400.0 % |
Sep 2023 | 2023-11-06 | $-0.07 | $-0.11 | 36.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $7.26M | $11.05M | -34.3 % |
Mar 2024 | 2024-05-14 | $25.38M | $18.88M | 34.4 % |
Dec 2023 | 2024-03-21 | $9.74M | $8.67M | 12.3 % |
Sep 2023 | 2023-11-06 | $6.52M | $5.42M | 20.2 % |
Fennec Pharmaceuticals (FENC) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.20, which missed the estimate of $-0.03.
The Actual Revenue was $7.3M, which missed the estimate of $11.1M.
Browse earnings estimates, EPS, and revenue on all stocks.